Advances in research of interchangeable immunization with live attenuated Japanese encephalitis vaccines and inactivated vaccines.
10.3760/cma.j.cn112150-20211110-01044
- Author:
Xuan DENG
1
;
Han Qing HE
1
;
Yang ZHOU
1
;
Rui YAN
1
;
Xue Wen TANG
1
;
Yao ZHU
1
;
Xiao Ping XU
1
;
Hua Kun LYU
1
Author Information
1. Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China.
- Publication Type:Journal Article
- MeSH:
Encephalitis Virus, Japanese;
Encephalitis, Japanese/prevention & control*;
Humans;
Immunization;
Japanese Encephalitis Vaccines;
Vaccination;
Vaccines, Inactivated
- From:
Chinese Journal of Preventive Medicine
2022;56(5):554-560
- CountryChina
- Language:Chinese
-
Abstract:
Japanese encephalitis (JE) virus is the leading cause of vaccine-preventable encephalitis in Asia and the Western Pacific, which mainly invades central nervous system. Vaccination is the most important strategy to prevent JE. Currently, both live attenuated Japanese encephalitis vaccines (JE-L) and inactivated vaccines (JE-I) are in use. Due to the supply of vaccines and the personal choice of recipients, there will be a demand for interchangeable immunization of these two vaccines. However, relevant research is limited. By reviewing domestic and foreign research evidence, this article summarizes the current situation of the interchangeable use of JE-L and JE-I, and makes recommendations when the interchangeable immunization is in urgent need, so as to provide reference for practical vaccination and policymaking in China.
